回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读

doi:10.16150/j.1671-2870.2021.04.004

摘要/Abstract

关键词: 心血管疾病, 危险因素, 死亡率, 寿命损失

中图分类号:

R541.4

施仲伟. 回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021, 20(04): 349-355.

图/表 3

参考文献 27

[1]	Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action[J]. J Am Coll Cardiol, 2020,76(25):2980-2981. doi: 10.1016/j.jacc.2020.11.021 URL
[2]	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020, 396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9 URL
[3]	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disea-se Study 2019[J]. Lancet,2020, 396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2 URL
[4]	Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol,2020, 76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010 URL
[5]	Vekemans J, Gouvea-Reis F, Kim JH, et al. The path to group a Streptococcus Vaccines: World Health Organization research and development technology roadmap and preferred product characteristics[J]. Clin Infect Dis, 2019,69(5):877-883. doi: 10.1093/cid/ciy1143 pmid: 30624673
[6]	Yu K, Lv J, Qiu G, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study[J]. Lancet Glob Health, 2020,8(3):e430-e439.
[7]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021,36(6):521-545.
[8]	Moran A, Zhao D, Gu D, et al. The future impact of popu-lation growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Po-licy Model-China[J]. BMC Public Health, 2008,8:394. doi: 10.1186/1471-2458-8-394 URL
[9]	Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC International[J]. J Am Coll Cardiol, 2019,73(24):3135-3147. doi: 10.1016/j.jacc.2019.04.036 URL
[10]	Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nat Rev Cardiol, 2019,16(4):203-212. doi: 10.1038/s41569-018-0119-4 URL
[11]	Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013,381(9882):1987-2015. doi: 10.1016/S0140-6736(13)61097-1 URL
[12]	Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019,394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1 URL
[13]	Zhao D. Epidemiological features of cardiovascular di-sease in Asia[J]. JACC: Asia, 2021,1(1):1-13. doi: 10.1016/j.jacasi.2021.04.007 URL
[14]	李镒冲, 刘世炜, 曾新颖, 等. 1990-2016年中国及省级行政区心血管病疾病负担报告[J]. 中国循环杂志, 2019,34(8):729-740.
[15]	Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global Burden of disease study[J]. JAMA Cardiol, 2019,4(4):342-352. doi: 10.1001/jamacardio.2019.0295 URL
[16]	王文, 朱曼璐, 王拥军, 等. 《中国心血管病报告2012》概要[J]. 中国循环杂志, 2013,28(6):408-412.
[17]	Jiang B, Wang WZ, Chen H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities[J]. Stroke, 2006,37(1):63-68. pmid: 16306469
[18]	Zhang G, Yu C, Zhou M, et al. Burden of ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study[J]. BMC Cardiovasc Disord,2018, 18(1):18. doi: 10.1186/s12872-018-0761-0 URL
[19]	Dai H, Much AA, Maor E, et al. Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020:qcaa076.
[20]	Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet Glob Health, 2013,1(5):e259-e281.
[21]	GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med,2018, 379(25):2429-2437. doi: 10.1056/NEJMoa1804492 URL
[22]	Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives[J]. Int J Cardiol Heart Vasc, 2014,6:25-31.
[23]	GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019[J]. Lancet,2021, 397(10292):2337-2360. doi: 10.1016/S0140-6736(21)01169-7 URL
[24]	Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults[J]. Int J Cardiol, 2018,260:196-203. doi: S0167-5273(17)32606-2 pmid: 29622441
[25]	Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000[J]. N Engl J Med, 2007,356(23):2388-2398. doi: 10.1056/NEJMsa053935 URL
[26]	Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000[J]. Circulation,2004, 109(9):1101-1107. doi: 10.1161/01.CIR.0000118498.35499.B2 URL
[27]	Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J]. J Am Coll Cardiol, 2017,69(9):1116-1125.

疾病	1990年		2016年
疾病	死亡例数（n）	年龄标化死亡率（/10万）	死亡例数（n）	年龄标化死亡率（/10万）
心血管疾病
中国	2 245 278	332.3	4 344 334	268.1
美国	875 094	256.1	880 574	150.5
西欧国家	1 658 229	271.5	1 341 334	122.3
缺血性心脏病
中国	580 578	88.9	1 735746	109.7
美国	605 597	176.9	520 595	88.4
西欧国家	939 500	153.8	656 552	60.7
脑卒中
中国	1 267 953	184.2	2 098 212	125.5
美国	145 028	42.0	168 049	28.5
西欧国家	451 247	73.2	326 258	29.2

回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 3

参考文献 27

相关文章 15

编辑推荐

Metrics

本文评价

[1]	丁燕飞, 忻笑容, 周郁芬, 谢玲, 谷雷雷, 吴云林, 陈平. 上消化道溃疡伴出血患者溃疡愈合延迟的危险因素分析[J]. 诊断学理论与实践, 2022, 21(03): 312-316.
[2]	梁亚丽, 赵海港, 项广宇. 应激性高血糖比值预测急性缺血性脑卒中患者溶栓治疗后1年不良预后的价值[J]. 诊断学理论与实践, 2021, 20(06): 562-566.
[3]	刘安平, 凌枫, 史超, 孙璟. 上海社区老年脑卒中患者跌倒风险因素分析及风险识别模型的建立[J]. 诊断学理论与实践, 2021, 20(05): 475-479.
[4]	吴洁, 冯媛媛, 任妍, 曹久妹. 基于冠状动脉造影检查的高龄老年人群发生冠心病的危险因素调查及相应诊断模型的建立[J]. 诊断学理论与实践, 2021, 20(02): 201-206.
[5]	林雨轩, 赵延华, 王筱婧. 丙泊酚镇静下无痛胃镜术中低氧血症的发生率及危险因素分析[J]. 诊断学理论与实践, 2020, 19(06): 594-599.
[6]	吴歆, 耿旭强, 徐沪济. 多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020, 19(05): 540-543.
[7]	倪瀚文, 吴立群. 外泌体在心肌缺血及房颤诊治中的应用前景研究进展[J]. 诊断学理论与实践, 2020, 19(02): 199-202.
[8]	陈瑶瑶, 顾爱华. 氧化三甲胺与心血管疾病关系的研究进展[J]. 诊断学理论与实践, 2019, 18(2): 237-240.
[9]	魏晓敏, 张媛媛, 董樑, 夏敬文, 龚益, 喻永平, 李圣青. 真实世界中肺栓塞后慢性血栓栓塞性肺动脉高压的发病及相关危险因素前瞻性研究[J]. 诊断学理论与实践, 2019, 18(1): 37-43.
[10]	周妍, 顾祎. 血清维生素D水平与老年人社区获得性肺炎严重程度的相关性研究[J]. 诊断学理论与实践, 2017, 16(06): 612-616.
[11]	张诗, 何慧静, 万国斌. 200名晚期早产儿的盖塞尔婴幼儿智能评估量表的测试分析[J]. 诊断学理论与实践, 2017, 16(02): 217-220.
[12]	周嘉, 罗悦玲, 李励, 冼晶, 梁杏欢, 黄振兴, 秦映芬, 罗佐杰,. 广西40岁以上人群代谢综合征及其危险因素调查[J]. 诊断学理论与实践, 2016, 15(04): 364-370.
[13]	王芳, 章安迪,. 伴有多种危险因素的冠心病患者支架内再狭窄的影响因素[J]. 诊断学理论与实践, 2016, 15(03): 280-282.
[14]	陈淳, 王家莉, 季承博, 布阿提卡木, 彭亦雩, 傅毅,. 抵抗素与脑梗死及其危险因素的相关性研究[J]. 诊断学理论与实践, 2015, 14(03): 279-282.
[15]	李畅, 董海蕴, 苏侃, 顾刚,. 心律植入装置感染相关危险因素分析[J]. 诊断学理论与实践, 2015, 14(02): 142-145.